Amgen Inc on Wednesday said third-quarter adjusted profit rose 17% due to stronger sales of drugs such as osteoporosis treatment Prolia and psoriasis medication Otezla, bucking challenges from lower ...
India-based Biocon’s biosimilars subsidiary has reached a settlement and license agreement with Amgen that clears the path ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback